Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.

Anti-Depressants vs Physiotherapy in Management of Fibromyalgia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00704899
Recruitment Status : Completed
First Posted : June 25, 2008
Last Update Posted : July 4, 2008
Information provided by:
Mahatma Gandhi Institute of Medical Sciences

Brief Summary:
To compare the efficacy of physiotherapy and anti-depressants in disability reduction in patients of Fibromyalgia syndrome.

Condition or disease Intervention/treatment Phase
Fibromyalgia Procedure: Physiotherapy Drug: Amitryptiline Phase 3

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 175 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Effect of Anti-Depressants vs Physiotherapy in Management of Fibromyalgia Syndrome: What Predicts a Clinical Benefit?
Study Start Date : March 2006
Actual Primary Completion Date : December 2007
Actual Study Completion Date : April 2008

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: 2
Drug: Amitryptiline
Amitryptiline 25mg once daily

Experimental: 1
Procedure: Physiotherapy
Structured exercise regimen

Primary Outcome Measures :
  1. Reduction in FIQ score from the baseline [ Time Frame: Two years ]

Secondary Outcome Measures :
  1. Reduction in Tender point score [ Time Frame: Two years ]
  2. Reduction in Brief psychiatric rating score [ Time Frame: Two Years ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patient's between 18-60 yrs, belonging to either sex. With symptoms of chronic muscular pain of at least 12 weeks (that may or may not be consecutive) who fulfill the American College of Rheumatology (ACR) criteria for the diagnosis of Fibromyalgia

Exclusion Criteria:

  • Patients of age group more than 60 yrs and below 18 years
  • Pregnant or lactating females.
  • Patients with a history of trauma.
  • Patients with severe co morbid illness which prevents physical activity (for example, cardiovascular problems)
  • Patients with the presence of specific medical disorders which require immediate treatment (for example, fractures, infectious diseases),
  • Patients with associated neurological abnormality

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00704899

Layout table for location information
Mahatma Gandhi Institute of Medical Sciences
Sevagram, Maharashtra, India, 442102
Sponsors and Collaborators
Mahatma Gandhi Institute of Medical Sciences

Layout table for additonal information
Responsible Party: Prof AP Jain, Department of Medicine, MGIMS Sevagram Identifier: NCT00704899    
Other Study ID Numbers: MGIMS-001
First Posted: June 25, 2008    Key Record Dates
Last Update Posted: July 4, 2008
Last Verified: June 2008
Additional relevant MeSH terms:
Layout table for MeSH terms
Myofascial Pain Syndromes
Muscular Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Neuromuscular Diseases
Nervous System Diseases
Amitriptyline, perphenazine drug combination
Antidepressive Agents
Antidepressive Agents, Tricyclic
Psychotropic Drugs
Analgesics, Non-Narcotic
Sensory System Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Adrenergic Uptake Inhibitors
Neurotransmitter Uptake Inhibitors
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Adrenergic Agents
Neurotransmitter Agents
Antipsychotic Agents
Tranquilizing Agents
Central Nervous System Depressants